Court: Some bone marrow donors can be paid

By PAUL ELIAS , Associated Press

(AP) -- A federal appeals court ruled Thursday that most bone marrow donors can be paid, overturning a decades-old law that made such compensation a crime.

In its ruling Thursday, the 9th U.S. Circuit of Appeals said a makes donating a nearly identical process as donating blood plasma. It's legal - and common - to pay plasma donors. Therefore, the court ruled, bone marrow donors undergoing the new procedure can be paid as well and are exempt from a law making it a felony to sell for transplants.

The unanimous three-judge panel of the court did say it remains a felony to compensate donors for undergoing the older donation method, which extracts the marrow from the donors' bones.

The ruling overturns a lower court decision barring compensation for all bone marrow donations.

MoreMarrowDonors.org brought the case, seeking to offer donors $3,000 in the form of a scholarship, housing allowance or gift to charity.

At the heart of the court's ruling, which is sure to ignite renewed debate over paying medical donors, are two processes for transplanting bone marrow into patients suffering from diseases of the blood.

The first and older one is known as "aspiration" and requires the donor to endure painful and risky procedures that require hospitalization and anesthesia. Long, thick needles are inserted into the of the donor's hip bones to suck out the bone marrow. The court said that process was still covered by the National Organ Transplant Act, which explicitly prohibits paying donors for their bone marrow.

The newer procedure, which the court ruled exempt from the act, was developed about 20 years ago and involves harvesting cells from the bloodstream rather than in bone. Called "apheresis," the procedure requires the donor to undergo five days of drug injections to stimulate production of specialized . Then the donor sits in a recliner for several hours while the blood is filtered through a machine that extracts the specialized cells.

The court said the newer process isn't covered by the law because actual "bone marrow" isn't taken from the donor. The court said that the new process is basically a blood donation and noted that two-thirds of bone marrow transplants employ the newer process.

"It may be that `bone marrow transplant' is an anachronism that will soon fade away, as peripheral blood stem cell apheresis replaces as the transplant technique, much as `dial the phone' is fading away now that telephones do not have dials," Judge Andrew Kleinfeld wrote for the court.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Marrow program tapping into Web for donors

Nov 12, 2007

Organizers of a Web-based bone marrow donation campaign said they're looking to expand their efforts to recruit more South Asians for the U.S. registry.

Research shows cord blood comparable to matched bone marrow

Jun 08, 2007

University of Minnesota researchers report that umbilical cord blood transplants may offer blood cancer patients better outcomes than bone marrow transplants, according to an analysis of outcome data performed at the Center ...

The Medical Minute: Donate life

Apr 14, 2011

Who wants to be a hero? No, it’s not a new TV reality show, it’s a real question. You can make a heroic gesture now by becoming an organ donor. It’s very simple to do. In Pennsylvania, as in most states, you ...

Recommended for you

The impact of bacteria in our guts

7 hours ago

The word metabolism gets tossed around a lot, but it means much more than whether you can go back to the buffet for seconds without worrying about your waistline. In fact, metabolism is the set of biochemical ...

Stem cell therapies hold promise, but obstacles remain

8 hours ago

(Medical Xpress)—In an article appearing online today in the journal Science, a group of researchers, including University of Rochester neurologist Steve Goldman, M.D., Ph.D., review the potential and ch ...

New hope in fight against muscular dystrophy

9 hours ago

Research at Stockholm's KTH Royal Institute of Technology offers hope to those who suffer from Duchenne muscular dystrophy, an incurable, debilitating disease that cuts young lives short.

Biologists reprogram skin cells to mimic rare disease

Aug 21, 2014

Johns Hopkins stem cell biologists have found a way to reprogram a patient's skin cells into cells that mimic and display many biological features of a rare genetic disorder called familial dysautonomia. ...

User comments